vs

Side-by-side financial comparison of Applied Materials (AMAT) and Emerson Electric (EMR). Click either name above to swap in a different company.

Applied Materials is the larger business by last-quarter revenue ($6.8B vs $4.3B, roughly 1.6× Emerson Electric). Applied Materials runs the higher net margin — 27.9% vs 13.9%, a 14.0% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs -3.5%). Applied Materials produced more free cash flow last quarter ($2.0B vs $602.0M). Over the past eight quarters, Applied Materials's revenue compounded faster (0.7% CAGR vs -0.3%).

Applied Materials, Inc. is an American corporation that supplies equipment, services and software for the manufacture of semiconductor chips for electronics, flat panel displays for computers, smartphones, televisions, and solar products. The company also supplies equipment to produce coatings for flexible electronics, packaging and other applications. The company is headquartered in Santa Clara, California, and is the second largest supplier of semiconductor equipment in the world based on r...

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

AMAT vs EMR — Head-to-Head

Bigger by revenue
AMAT
AMAT
1.6× larger
AMAT
$6.8B
$4.3B
EMR
Growing faster (revenue YoY)
EMR
EMR
+7.6% gap
EMR
4.1%
-3.5%
AMAT
Higher net margin
AMAT
AMAT
14.0% more per $
AMAT
27.9%
13.9%
EMR
More free cash flow
AMAT
AMAT
$1.4B more FCF
AMAT
$2.0B
$602.0M
EMR
Faster 2-yr revenue CAGR
AMAT
AMAT
Annualised
AMAT
0.7%
-0.3%
EMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AMAT
AMAT
EMR
EMR
Revenue
$6.8B
$4.3B
Net Profit
$1.9B
$605.0M
Gross Margin
48.0%
53.2%
Operating Margin
25.2%
17.8%
Net Margin
27.9%
13.9%
Revenue YoY
-3.5%
4.1%
Net Profit YoY
9.6%
3.4%
EPS (diluted)
$2.36
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMAT
AMAT
EMR
EMR
Q4 25
$6.8B
$4.3B
Q3 25
$7.3B
$4.9B
Q2 25
$7.1B
$4.6B
Q1 25
$7.2B
$4.4B
Q4 24
$7.0B
$4.2B
Q3 24
$6.8B
$4.6B
Q2 24
$6.6B
$4.4B
Q1 24
$6.7B
$4.4B
Net Profit
AMAT
AMAT
EMR
EMR
Q4 25
$1.9B
$605.0M
Q3 25
$1.8B
$637.0M
Q2 25
$2.1B
$586.0M
Q1 25
$1.2B
$485.0M
Q4 24
$1.7B
$585.0M
Q3 24
$1.7B
$996.0M
Q2 24
$1.7B
$329.0M
Q1 24
$2.0B
$501.0M
Gross Margin
AMAT
AMAT
EMR
EMR
Q4 25
48.0%
53.2%
Q3 25
48.8%
51.9%
Q2 25
49.1%
52.6%
Q1 25
48.8%
53.5%
Q4 24
47.3%
53.5%
Q3 24
47.3%
51.3%
Q2 24
47.4%
52.8%
Q1 24
47.8%
52.2%
Operating Margin
AMAT
AMAT
EMR
EMR
Q4 25
25.2%
17.8%
Q3 25
30.6%
16.4%
Q2 25
30.5%
16.1%
Q1 25
30.4%
14.2%
Q4 24
29.0%
18.6%
Q3 24
28.7%
14.7%
Q2 24
28.8%
10.4%
Q1 24
29.3%
16.2%
Net Margin
AMAT
AMAT
EMR
EMR
Q4 25
27.9%
13.9%
Q3 25
24.4%
13.1%
Q2 25
30.1%
12.9%
Q1 25
16.5%
10.9%
Q4 24
24.6%
14.0%
Q3 24
25.2%
21.6%
Q2 24
25.9%
7.5%
Q1 24
30.1%
11.4%
EPS (diluted)
AMAT
AMAT
EMR
EMR
Q4 25
$2.36
$1.07
Q3 25
$2.22
$1.12
Q2 25
$2.63
$1.04
Q1 25
$1.45
$0.86
Q4 24
$2.09
$1.02
Q3 24
$2.05
$1.74
Q2 24
$2.06
$0.57
Q1 24
$2.41
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMAT
AMAT
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$8.6B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$20.4B
$20.3B
Total Assets
$36.3B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMAT
AMAT
EMR
EMR
Q4 25
$8.6B
Q3 25
$7.0B
Q2 25
$6.7B
Q1 25
$8.2B
Q4 24
$9.5B
Q3 24
$9.1B
Q2 24
$7.6B
Q1 24
$7.5B
Total Debt
AMAT
AMAT
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
AMAT
AMAT
EMR
EMR
Q4 25
$20.4B
$20.3B
Q3 25
$19.5B
$20.3B
Q2 25
$19.0B
$19.9B
Q1 25
$18.6B
$19.2B
Q4 24
$19.0B
$20.5B
Q3 24
$18.8B
$21.6B
Q2 24
$18.2B
$20.8B
Q1 24
$17.4B
$20.9B
Total Assets
AMAT
AMAT
EMR
EMR
Q4 25
$36.3B
$41.9B
Q3 25
$34.2B
$42.0B
Q2 25
$33.6B
$42.5B
Q1 25
$33.3B
$42.0B
Q4 24
$34.4B
$42.6B
Q3 24
$33.6B
$44.2B
Q2 24
$31.9B
$45.6B
Q1 24
$31.5B
$46.4B
Debt / Equity
AMAT
AMAT
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMAT
AMAT
EMR
EMR
Operating Cash FlowLast quarter
$2.8B
$699.0M
Free Cash FlowOCF − Capex
$2.0B
$602.0M
FCF MarginFCF / Revenue
30.0%
13.9%
Capex IntensityCapex / Revenue
11.5%
2.2%
Cash ConversionOCF / Net Profit
1.49×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$5.7B
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMAT
AMAT
EMR
EMR
Q4 25
$2.8B
$699.0M
Q3 25
$2.6B
$3.1B
Q2 25
$1.6B
$1.1B
Q1 25
$925.0M
$241.0M
Q4 24
$2.6B
$777.0M
Q3 24
$2.4B
$3.3B
Q2 24
$1.4B
$1.1B
Q1 24
$2.3B
$743.0M
Free Cash Flow
AMAT
AMAT
EMR
EMR
Q4 25
$2.0B
$602.0M
Q3 25
$2.0B
$2.7B
Q2 25
$1.1B
$977.0M
Q1 25
$544.0M
$154.0M
Q4 24
$2.2B
$694.0M
Q3 24
$2.1B
$2.9B
Q2 24
$1.1B
$998.0M
Q1 24
$2.1B
$661.0M
FCF Margin
AMAT
AMAT
EMR
EMR
Q4 25
30.0%
13.9%
Q3 25
28.1%
54.9%
Q2 25
14.9%
21.5%
Q1 25
7.6%
3.5%
Q4 24
30.8%
16.6%
Q3 24
30.8%
63.1%
Q2 24
17.1%
22.8%
Q1 24
31.3%
15.1%
Capex Intensity
AMAT
AMAT
EMR
EMR
Q4 25
11.5%
2.2%
Q3 25
8.0%
8.9%
Q2 25
7.2%
2.0%
Q1 25
5.3%
2.0%
Q4 24
5.8%
2.0%
Q3 24
4.4%
9.1%
Q2 24
3.9%
2.1%
Q1 24
3.4%
1.9%
Cash Conversion
AMAT
AMAT
EMR
EMR
Q4 25
1.49×
1.16×
Q3 25
1.48×
4.86×
Q2 25
0.74×
1.83×
Q1 25
0.78×
0.50×
Q4 24
1.49×
1.33×
Q3 24
1.40×
3.35×
Q2 24
0.81×
3.31×
Q1 24
1.15×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMAT
AMAT

Semiconductor Systems Segment$4.8B70%
Applied Global Services Segment$1.6B24%
Other$415.0M6%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons